Mariner
MIST icon

Mariner’s Milestone Pharmaceuticals MIST Stock Holding History

Mariner’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$36.7K Buy
30,830
+5,830
+23% +$10.2K ﹤0.01% 3452
2025
Q4 		$50.5K Hold
25,000
– – ﹤0.01% 3412
2025
Q3 		$50K Buy
25,000
+14,000
+127% +$24.6K ﹤0.01% 3447
2025
Q2 		$21.3K Buy
+11,000
New +$14.7K ﹤0.01% 3417

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Mariner's MIST Position: Q1 2026 in Review

Mariner increased its Milestone Pharmaceuticals (MIST) stake by 23% in Q1 2026, buying an estimated $10.2K and bringing the position to 30,830 shares worth $36.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3452.

Mariner first reported a position in MIST in Q2 2025 and has held it in 4 quarters since. The position peaked at $50.5K in Q4 2025. 86 funds tracked by Wall St. Rank hold MIST as of Q1 2026.

  • Mariner held 30,830 shares of Milestone Pharmaceuticals worth $36.7K as of Q1 2026.
  • Mariner bought 5,830 Milestone Pharmaceuticals shares in Q1 2026, an estimated $10.2K.
  • Milestone Pharmaceuticals made up ﹤0.01% of Mariner's portfolio in Q1 2026, its #3452 holding.
  • Mariner first reported a position in Milestone Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • Mariner's Milestone Pharmaceuticals position peaked at $50.5K in Q4 2025.
  • 86 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.